Affymax, (FRA:A5Y) Receivables Turnover : 0.00 (As of Jun. 2014)

View and export this data going back to . Start your Free Trial

What is Affymax, Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Affymax,'s Revenue for the three months ended in Jun. 2014 was €0.03 Mil. Affymax,'s average Accounts Receivable for the three months ended in Jun. 2014 was €0.00 Mil.

Affymax, Receivables Turnover Historical Data

The historical data trend for Affymax,'s Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymax, Receivables Turnover Chart

Affymax, Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Receivables Turnover

Get a 7-Day Free Trial

5.48

6.68

Affymax, Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Affymax,'s Receivables Turnover

For the Biotechnology subindustry, Affymax,'s Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Affymax,'s Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affymax,'s Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Affymax,'s Receivables Turnover falls into.

Affymax, Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Affymax,'s Receivables Turnover for the fiscal year that ended in Dec. 2013 is calculated as

	Receivables Turnover (A: Dec. 2013 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2013 )	/ (	(Accounts Receivable (A: Dec. 2012 )	+	Accounts Receivable (A: Dec. 2013 ))	/	count )
=	0.999	/ (	(0	+	0)	/	1 )
=	0.999	/	0
=	N/A

Affymax,'s Receivables Turnover for the quarter that ended in Jun. 2014 is calculated as

	Receivables Turnover (Q: Jun. 2014 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2014 )	/ (	(Accounts Receivable (Q: Mar. 2014 )	+	Accounts Receivable (Q: Jun. 2014 ))	/	count )
=	0.031	/ (	(0	+	0)	/	1 )
=	0.031	/	0
=	N/A

Affymax, (FRA:A5Y) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Affymax, Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Affymax,'s Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Affymax, (FRA:A5Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affymax, Inc. (FRA:A5Y) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020

Website

http://www.affymax.com

Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

Affymax, (FRA:A5Y) Headlines

No Headlines